Halog 1 mg/g
Halcinonide Cream · CREAM · Genus Lifesciences Inc.
Halog is a cream containing halcinonide cream at 1 mg/g, taken topical. Manufactured by Genus Lifesciences Inc..
Key Facts
- Brand Name
- Halog
- Generic Name
- Halcinonide Cream
- NDC Code (Product)
64950-126- Manufacturer
- Genus Lifesciences Inc.
- Strength
- 1 mg/g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Application #
- NDA017556
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 01/13/2026
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
INDICATIONS AND USAGE HALOG SOLUTION (Halcinonide Topical Solution, USP) 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage & Administration
DOSAGE AND ADMINISTRATION Apply HALOG SOLUTION (Halcinonide Topical Solution, USP) 0.1% to the affected area two to three times daily. Occlusive Dressing Technique Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions. Apply the solution to the lesion, cover with a pliable nonporous film, and seal the edges. If needed, additional moisture may be provided by covering the lesion with a dampened clean cotton cloth before the nonporous film is applied or by briefly wetting the affected area with water immediately prior to applying the medication. The frequency of changing dressings is best determined on an individual basis. It may be convenient to apply Halcinonide Topical Solution, USP 0.1% under an occlusive dressing in the evening and to remove the dressing in the morning (i.e., 12-hour occlusion). When utilizing the 12-hour occlusion regimen, additional solution should be applied, without occlusion, during the day. Reapplication is essential at each dressing change. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Contraindications
CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.
Adverse Reactions
ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings (reactions are listed in an approximate decreasing order of occurrence): burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
Frequently Asked Questions
What is Halog used for?
Halog contains Halcinonide Cream. It is a cream taken topical. Consult your doctor for specific uses.
Is Halog a controlled substance?
Halog is not classified as a controlled substance by the DEA.
What is the generic name for Halog?
The generic name for Halog is Halcinonide Cream. There are no other listed brand versions of Halcinonide Cream.
What is the NDC code for Halog 1 mg/g?
The NDC (National Drug Code) for Halog 1 mg/g is 64950-126, listed by Genus Lifesciences Inc..
Other Halog Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)